4//SEC Filing
Paulsen Gisela 4
Accession 0001493152-22-035990
CIK 0001642380other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:05 PM ET
Size
11.8 KB
Accession
0001493152-22-035990
Insider Transaction Report
Form 4
Paulsen Gisela
Former President and COO
Transactions
- Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−70,313→ 54,687 totalExercise: $1.15→ Common Stock (70,313 underlying) - Disposition to Issuer
Common Stock, no par value
2022-12-01−175,000→ 366,500 total - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−171,875→ 203,125 totalExercise: $3.42→ Common Stock (171,875 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−125,000→ 0 totalExercise: $1.15→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022.
- [F2]The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001807104
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:05 PM ET
- Size
- 11.8 KB